Increased levels of CTSZ were detected in CSF collected from CLN1 and CLN2 disease mice (Sleat et al., 2019), as well as in urine collected from CLN2 disease patients (Iwan et al., 2020). Here, TPP1 is linked to glycogen storage disease VI.